Insulin degludec and liraglutide Subcutaneous and Skyrizi (150 MG Dose)
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Skyrizi (150 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Skyrizi Injection
- Insulin degludec and liraglutide Subcutaneous-Skyrizi topical
- Insulin degludec and liraglutide Subcutaneous-Sleep Aid
- Insulin degludec and liraglutide Subcutaneous-Sleep Aid Tablets
- Insulin degludec and liraglutide Subcutaneous-Sleepinal
- Insulin degludec and liraglutide Subcutaneous-Slo-Niacin
- Skyrizi (150 MG Dose)-Insulin degludec Subcutaneous
- Skyrizi (150 MG Dose)-Insulin detemir
- Skyrizi (150 MG Dose)-Insulin Detemir (Cartridges and Prefilled Syringes)
- Skyrizi (150 MG Dose)-Insulin Detemir (Vials)
- Skyrizi (150 MG Dose)-Insulin detemir Subcutaneous
- Skyrizi (150 MG Dose)-Insulin glargine